Parametric Portfolio Associates’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Parametric Portfolio Associates’s Portfolio GEVA Stock Details GEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-7,556	Closed	-$737K	–	4056
2015 Q1	$737K	Buy	7,556 +137	+2%	+$14.5K	﹤0.01%	3007
2014 Q4	$688K	Buy	+7,419	New	+$585K	﹤0.01%	3065
2014 Q3	–	Sell	-3,141	Closed	-$329K	–	3913
2014 Q2	$329K	Buy	3,141 +709	+29%	+$60.3K	﹤0.01%	3465
2014 Q1	$202K	Buy	+2,432	New	+$225K	﹤0.01%	3624

Parametric Portfolio Associates's GEVA Position: Q2 2015 in Review

Parametric Portfolio Associates sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 7,556 shares — an estimated $737K sold.

Parametric Portfolio Associates first reported a position in GEVA in Q1 2014 and held it in 4 quarters. The position peaked at $737K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

Parametric Portfolio Associates reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Parametric Portfolio Associates sold 7,556 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $737K.
Parametric Portfolio Associates first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2014 and held it in 4 quarters.
Parametric Portfolio Associates's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $737K in Q1 2015.
0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Parametric Portfolio Associates's 13F filing for Q2 2015, filed 14 Aug 2015.